Logo

Genetworx Gets CAP Accreditation

Dec 13, 2013 | staff reporter

NEW YORK (GenomeWeb News) – Genetworx announced Thursday that it has received accreditation from the College of American Pathologists for its clinical lab in Glen Allen, Va.

The firm offers genetic testing services and provides physicians with clinically referenced information to facilitate individualized treatment plans based on a patient's DNA. Its portfolio includes tests targeting variations in cytochrome P450 2C19, cytochrome P450 2C9 and VKORC1, cytochrome P450 2D6, and others

Genetworx is now both CLIA certified and CAP accredited for clinical sample processing of buccal swab samples for genotyping of drug-metabolizing enzymes and thrombophilia risk factors.

Filed under

Diagnostics
Regulatory News & FDA Approvals
CAP
pharmacogenomics
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.